"KB Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
This line KB is now known to be a subline of the ubiquitous KERATIN-forming tumor cell line HeLa. It was originally thought to be derived from an epidermal carcinoma of the mouth, but was subsequently found, based on isoenzyme analysis, HeLa marker chromosomes, and DNA fingerprinting, to have been established via contamination by HELA CELLS. The cells are positive for keratin by immunoperoxidase staining. KB cells have been reported to contain human papillomavirus18 (HPV-18) sequences.
| Descriptor ID |
D007624
|
| MeSH Number(s) |
A11.251.210.190.400.500 A11.251.860.180.400.500 A11.436.340.500
|
| Concept/Terms |
KB Cells- KB Cells
- Cell, KB
- Cells, KB
- KB Cell
- HeLa-KB Cells
- Cell, HeLa-KB
- Cells, HeLa-KB
- HeLa KB Cells
- HeLa-KB Cell
|
Below are MeSH descriptors whose meaning is more general than "KB Cells".
Below are MeSH descriptors whose meaning is more specific than "KB Cells".
This graph shows the total number of publications written about "KB Cells" by people in this website by year, and whether "KB Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "KB Cells" by people in Profiles.
-
Redox potential ultrasensitive nanoparticle for the targeted delivery of camptothecin to HER2-positive cancer cells. Mol Pharm. 2014 Jun 02; 11(6):1897-905.
-
Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery. Mol Pharmacol. 2004 Dec; 66(6):1406-14.
-
Screening and discovery of novel MDR modifiers from naturally occurring bisbenzylisoquinoline alkaloids. Anticancer Res. 2001 Jul-Aug; 21(4A):2273-80.
-
Antagonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy. Clin Cancer Res. 1999 Sep; 5(9):2559-65.
-
Apoptotic cell death induced by baccatin III, a precursor of paclitaxel, may occur without G(2)/M arrest. Cancer Chemother Pharmacol. 1999; 44(6):444-52.
-
5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells. Clin Cancer Res. 1997 Oct; 3(10):1739-45.
-
Synthesis of green fluorescent protein-ricin and monitoring of its intracellular trafficking. Bioconjug Chem. 1997 Sep-Oct; 8(5):743-50.
-
Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci U S A. 1990 Sep; 87(18):7225-9.
-
Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A. 1990 09; 87(18):7160-4.
-
mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucleic Acids Res. 1988 Nov 11; 16(21):10366.